Off Targets Limited

Off Targets Limited is a pharmaceutical innovation company headquartered in London that specializes in the development of complex injectable formulations and the identification of new therapeutic indications for existing drugs. The company utilizes a multidisciplinary approach that combines various artificial intelligence and machine learning platforms with biochemical and cell-based assays. By integrating computational and experimental methodologies, the company aims to create a systematic, logical framework for drug discovery that is more efficient than serendipitous methods. Their R&D operations, which include a presence in Bangalore, India, focus on delivering ready-to-transfer technologies across areas such as central nervous system (CNS) disorders, oncology, and critical care.

This work is particularly significant for addressing unmet medical needs, especially regarding rare, neglected, and difficult-to-treat diseases. By focusing on drug repurposing, the company leverages existing safety, pharmacokinetic, and manufacturing data to expedite the development of innovative medications. This approach provides a streamlined path for bringing specialized treatments to hospital and institutional markets globally. Through its focus on complex injectables and strategic R&D, Off Targets Limited positions itself as a partner for pharmaceutical development, aiming to advance healthcare solutions through its specialized technological capabilities.